This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berner, R. Articles by Schütt, C. Search for Related Content PubMed PubMed Citation Articles by Berner, R. Articles by Schütt, C.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, March 2002, p. 440-445, Vol. 9, No. 2
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.2.440-445.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Elevated Levels of Lipopolysaccharide-Binding Protein and Soluble CD14 in Plasma in Neonatal Early-Onset Sepsis

University Children's Hospital, D-79106 Freiburg,¹ Institute for Immunology and Transfusion Medicine, University of Greifswald, D-17487 Greifswald, Germany²

Received 25 June 2001/ Returned for modification 4 October 2001/ Accepted 25 October 2001

No data on lipopolysaccharide-binding protein (LBP) in newborns with sepsis have been available up to now. We therefore determined levels of LBP and soluble CD14 (sCD14) in plasma of healthy and septic neonates in order to evaluate their potential diagnostic role. The study included prospectively collected patient samples of two recently published studies on cytokine expression in neonatal sepsis. Twenty-nine septic patients were enrolled in the present analysis. Samples—either cord blood or peripheral blood—from patients admitted within the first 24 h of life for suspicion of sepsis and cord blood samples of a control group of 40 healthy mature infants delivered spontaneously were analyzed. For seven patients of the septic group, a second sample collected between 24 and 48 h of life was available. Levels of sCD14 and LBP in plasma were determined by an enzyme immunoassay using recombinant CD14 and LBP as standards. LBP and sCD14 were correlated to cytokine plasma levels. In septic neonates, LBP (median, 36.6 versus 7.8 µg/ml; P < 0.001) and sCD14 (median, 0.42 versus 0.28 µg/ml; P < 0.001) levels were highly elevated when compared to those of healthy neonates and strongly correlated to granulocyte colony-stimulating factor (G-CSF), interleukin-1ß (IL-1ß), IL-6, and IL-8 levels. LBP levels in septic neonates analyzed between 24 and 48 h of life even increased when compared to samples obtained at or shortly after delivery (median, 36.6 versus 60 µg/ml; P = 0.038). In summary, levels of LBP in plasma of neonates with early-onset sepsis are significantly elevated; the elevated plasma levels seem to persist for more than 24 h, which could provide the clinician with a prolonged time period to identify the newborn with bacterial sepsis.

This article has been cited by other articles:

• Behrendt, D, Dembinski, J, Heep, A, Bartmann, P (2004). Lipopolysaccharide binding protein in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 89: F551-F554 [Abstract] [Full Text]  
• Ng, P C (2004). Diagnostic markers of infection in neonates. Arch. Dis. Child. Fetal Neonatal Ed. 89: F229-F235 [Abstract] [Full Text]